The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Blood creatinine increased 5
RITUXIMAB Blood lactic acid increased 5
RITUXIMAB Body temperature increased 5
Rituximab Bronchiectasis 5
RITUXIMAB C-reactive protein increased 5
rituximab Cardiac disorder 5
Rituximab Cholecystitis 5
Rituximab Cholecystitis acute 5
RITUXIMAB Disorientation 5
Rituximab Dysphonia 5
RITUXIMAB Epistaxis 5
Rituximab Febrile bone marrow aplasia 5
Rituximab Gamma-glutamyltransferase increased 5
Rituximab Hepatitis 5
rituximab Hepatitis acute 5
Rituximab Hepatitis D 5
Rituximab Hepatocellular injury 5
Rituximab Hepatorenal syndrome 5
Rituximab Histiocytosis haematophagic 5
Rituximab Infarction 5

Total Records: 1,104     Number of Pages: 56